Low antigen abundance limits efficient T-cell recognition of highly conserved regions of SARS-CoV-2
Swaminathan, S.; Lineburg, K.; Ambalathingal, G.; Crooks, P.; Grant, E.; Mohan, S.; Raju, J.; Panikkar, A.; Le Texier, L.; Tong, Z.; Chew, K.; Neller, M.; Gowda, H.; Short, K.; Gras, S.; Smith, C.; Khanna, R.
Show abstract
Understanding the immune response to severe acute respiratory syndrome coronavirus (SARS-CoV-2) is critical to overcome the current coronavirus disease (COVID-19) pandemic. Efforts are being made to understand the potential cross-protective immunity of memory T cells, induced by prior encounters with seasonal coronaviruses, in providing protection against severe COVID-19. In this study we assessed T-cell responses directed against highly conserved regions of SARS-CoV-2. Epitope mapping revealed 16 CD8+ T-cell epitopes across the nucleocapsid (N), spike (S) and ORF3a proteins of SARS-CoV-2 and five CD8+ T-cell epitopes encoded within the highly conserved regions of the ORF1ab polyprotein of SARS-CoV-2. Comparative sequence analysis showed high conservation of SARS-CoV-2 ORF1ab T-cell epitopes in seasonal coronaviruses. Paradoxically, the immune responses directed against the conserved ORF1ab epitopes were infrequent and subdominant in both convalescent and unexposed participants. This subdominant immune response was consistent with a low abundance of ORF1ab encoded proteins in SARS-CoV-2 infected cells. Overall, these observations suggest that while cross-reactive CD8+ T cells likely exist in unexposed individuals, they are not common and therefore are unlikely to play a significant role in providing broad pre-existing immunity in the community.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination 96%
- mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2 96%
- Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection 95%
Similar papers in this journal
- A systematic, unbiased mapping of CD8+ and CD4+ T cell epitopes in Yellow Fever vaccinees 96%
- CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus 96%
- Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level 95%
Similar papers in this journal
- SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells 95%
- A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1 95%
- Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial 95%
Similar papers in this journal
- Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers 95%
- HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses 94%
- ERAP1 allotypes 2 and 10 differentially regulate the immunopeptidome of melanocytes 94%
Similar papers in this journal
- Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles 96%
- COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins 96%
- Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.